Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermaNP Solutions is a South Korean biotechnology company specializing in the development of innovative dermatological treatments using advanced nanoparticle delivery systems. The company's primary focus is on overcoming the limitations of traditional topical therapies by enhancing the skin penetration and stability of active pharmaceutical ingredients. Its lead candidate, DNP-001, is a nanoparticle-encapsulated formulation designed to treat alopecia by targeting hair follicles more effectively than conventional solutions. DermaNP Solutions is also expanding its pipeline to include treatments for atopic dermatitis and other inflammatory skin conditions. The company leverages its proprietary platform to create next-generation cosmeceuticals and therapeutic agents with improved efficacy and reduced side effects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermaNP Solutions.